Global Blood Glucose Monitoring Systems Market 2018-2024
Global Blood Glucose Monitoring Systems Market – Drivers, Restraints, Opportunities, Trends, and Forecast: 2018–2024
Overview: Blood glucose monitoring is an integral part of the standard diabetes care, and it is very helpful in controlling the glucose levels in individuals with diabetes and impaired glucose tolerance. The incidence of diabetes is increasing globally, and around 90% of the patients have type 2 diabetes mellitus with approximately one-fifth of the people undergoing insulin treatment. Self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems are two major types of blood glucose monitoring systems.
The market for blood glucose monitoring systems is driven by increasing incidence of diabetes across various geographies, huge surge in the aging population, and increasing product launch and approvals. Increasing collaboration and funding to develop innovative devices and raising awareness among the patients are providing an opportunity for the market growth. Product recalls and inadequate reimbursements are few of the factors that may hamper the market growth to an extent.
Market Analysis: The “Global Blood Glucose Monitoring Systems” market is estimated to witness a CAGR of 6.7% during the forecast period 2018–2024. The global market is analyzed based on four segments – products, applications, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is the major shareholder in the global blood glucose monitoring systems market, followed by Europe. The Asia Pacific region is expected to grow at a high CAGR during the forecast period due to an upsurge in access to health care services, increasing patient pool, raising awareness among patients, and growing healthcare expenditure. According to the Asian Diabetes Prevention Initiative, nearly 60% of the total diabetic population resides in Asia. It also estimates that 65.1 million adults in India and 113.9 million adults in China have diabetes.
Product Analysis: The blood glucose monitoring systems market, by product, is segmented into self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems. SMBG systems occupied a significant market share in 2017, and CGM systems are expected to grow at a high CAGR during the forecast period. Increasing adoption of minimally invasive procedures makes it the fastest growing segment during the forecast period.
Application Analysis: The market, by applications, is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. Type 2 diabetes occupied a significant market share in 2017 and is expected to remain the same for the next 5 years. This is due to growing patient base for type 2 diabetes and increasing launch of the advanced product in this segment.
End-users Analysis: The market, by end-users, is segmented into hospitals, homecare, private clinics, and others. Among various end-users, homecare occupied a significant market share and is expected to remain the same during the forecast period.
Key Players: Medtronic plc, Johnson and Johnson, Abbott Laboratories, F. Hoffmann-La Roche Ltd., PHC Holdings Corporation, Ypsomed Holding, Dexcom, Acon Laboratories, Trividia Health Inc., Arkray Inc., Sanofi S.A., Terumo Medical Corporation, Prodigy Diabetes Care LLC, and niche players.
Competitive Analysis: The market has a large number of medium and small players that offer innovative products and has immense growth opportunity, especially in the emerging countries. The key market players are taking advantage of product approvals and new product launches, making their strategies to increase the market share. For instance, in September 2017, the US FDA approved FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip. In February 2018, Roche Diabetes Care India announced the launch of its new glucometer Accu-Chek Instant S, which marks the entry of the organization into the mass market segment in diabetes self-monitoring.
Benefits: The report provides complete details about the usage and adoption rate of blood glucose monitoring systems in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Overview: Blood glucose monitoring is an integral part of the standard diabetes care, and it is very helpful in controlling the glucose levels in individuals with diabetes and impaired glucose tolerance. The incidence of diabetes is increasing globally, and around 90% of the patients have type 2 diabetes mellitus with approximately one-fifth of the people undergoing insulin treatment. Self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems are two major types of blood glucose monitoring systems.
The market for blood glucose monitoring systems is driven by increasing incidence of diabetes across various geographies, huge surge in the aging population, and increasing product launch and approvals. Increasing collaboration and funding to develop innovative devices and raising awareness among the patients are providing an opportunity for the market growth. Product recalls and inadequate reimbursements are few of the factors that may hamper the market growth to an extent.
Market Analysis: The “Global Blood Glucose Monitoring Systems” market is estimated to witness a CAGR of 6.7% during the forecast period 2018–2024. The global market is analyzed based on four segments – products, applications, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is the major shareholder in the global blood glucose monitoring systems market, followed by Europe. The Asia Pacific region is expected to grow at a high CAGR during the forecast period due to an upsurge in access to health care services, increasing patient pool, raising awareness among patients, and growing healthcare expenditure. According to the Asian Diabetes Prevention Initiative, nearly 60% of the total diabetic population resides in Asia. It also estimates that 65.1 million adults in India and 113.9 million adults in China have diabetes.
Product Analysis: The blood glucose monitoring systems market, by product, is segmented into self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems. SMBG systems occupied a significant market share in 2017, and CGM systems are expected to grow at a high CAGR during the forecast period. Increasing adoption of minimally invasive procedures makes it the fastest growing segment during the forecast period.
Application Analysis: The market, by applications, is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. Type 2 diabetes occupied a significant market share in 2017 and is expected to remain the same for the next 5 years. This is due to growing patient base for type 2 diabetes and increasing launch of the advanced product in this segment.
End-users Analysis: The market, by end-users, is segmented into hospitals, homecare, private clinics, and others. Among various end-users, homecare occupied a significant market share and is expected to remain the same during the forecast period.
Key Players: Medtronic plc, Johnson and Johnson, Abbott Laboratories, F. Hoffmann-La Roche Ltd., PHC Holdings Corporation, Ypsomed Holding, Dexcom, Acon Laboratories, Trividia Health Inc., Arkray Inc., Sanofi S.A., Terumo Medical Corporation, Prodigy Diabetes Care LLC, and niche players.
Competitive Analysis: The market has a large number of medium and small players that offer innovative products and has immense growth opportunity, especially in the emerging countries. The key market players are taking advantage of product approvals and new product launches, making their strategies to increase the market share. For instance, in September 2017, the US FDA approved FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip. In February 2018, Roche Diabetes Care India announced the launch of its new glucometer Accu-Chek Instant S, which marks the entry of the organization into the mass market segment in diabetes self-monitoring.
Benefits: The report provides complete details about the usage and adoption rate of blood glucose monitoring systems in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
1 INDUSTRY OUTLOOK
1.1 Market Overview
1.2 Total addressable market
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Market Definition – Infoholic Research
3.2 Advantages of blood glucose monitoring systems
3.3 Segmented Addressable Market (SAM)
3.4 Trends of the blood glucose monitoring systems market
3.5 Related Markets
3.5.1 Insulin pump
3.5.2 Smart insulin pen
3.5.3 Insulin Syringes
4 MARKET OUTLOOK
4.1 Evolution of Blood Glucose Monitoring
4.2 Market segmentation
4.3 PEST Analysis
4.4 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 DRO – Global Blood Glucose Monitoring Systems Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing incidence of diabetes across various geographies
5.1.1.2 Increasing number of product launch and approvals
5.1.1.3 Huge surge in the aging population
5.1.2 Opportunities
5.1.2.1 New collaboration and funding to develop new devices
5.1.2.2 Growing patient awareness
5.1.3 Restraints
5.1.3.1 High cost and inadequate reimbursement
5.1.3.2 Product recalls
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 PRODUCTS: MARKET SIZE & ANALYSIS
6.1 Overview
6.2 Self-monitoring Blood Glucose Systems
6.3 Continuous Glucose Monitoring Systems
7 APPLICATION: MARKET SIZE & ANALYSIS
7.1 Overview
7.2 Type 1 Diabetes
7.3 Type 2 Diabetes
7.4 Gestational Diabetes
8 END-USER: MARKET SIZE & ANALYSIS
8.1 Overview
8.2 Hospitals
8.3 Homecare
8.4 Private clinics
8.5 Others
9 REGIONS: MARKET SIZE AND ANALYSIS
9.1 Overview
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World
10 COMPETITIVE LANDSCAPE
10.1 Overview
11 VENDOR PROFILES
11.1 Medtronic plc
11.1.1 Overview
11.1.2 Medtronic plc: Recent Developments
11.1.3 Business Units
11.1.4 Geographic Revenue
11.1.5 Business Focus
11.1.6 SWOT Analysis
11.1.7 Business Strategies
11.2 Abbott Laboratories
11.2.1 Overview
11.2.2 Abbott Laboratories: Recent Developments
11.2.3 Business Units
11.2.4 Geographic Presence
11.2.5 Business Focus
11.2.6 SWOT Analysis
11.2.7 Business Strategies
11.3 Johnson and Johnson
11.3.1 Overview
11.3.2 Business Units
11.3.3 Geographic Revenue
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 F.Hoffmann-La Roche Ltd.
11.4.1 Overview
11.4.2 Business Unit
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategy
12 COMPANIES TO WATCH FOR
12.1 Dexcom
12.1.1 Overview
12.2 PHC Holdings Corporation
12.2.1 Overview
12.3 Ypsomed Holding
12.3.1 Overview
12.4 B. Braun Melsungen AG
12.4.1 Overview
12.5 Trividia Health, Inc.
12.5.1 Overview
12.6 Acon Laboratories
12.6.1 Overview
12.7 Sanofi S.A.
12.7.1 Overview
12.8 Arkray, Inc.
12.8.1 Overview
12.9 Nova Biomedical Corporation
12.9.1 Overview
12.10 Prodigy Diabetes Care, LLC
12.10.1 Overview
12.11 Terumo Medical Corporation
12.11.1 Overview
Annexure
Acronyms
1.1 Market Overview
1.2 Total addressable market
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Market Definition – Infoholic Research
3.2 Advantages of blood glucose monitoring systems
3.3 Segmented Addressable Market (SAM)
3.4 Trends of the blood glucose monitoring systems market
3.5 Related Markets
3.5.1 Insulin pump
3.5.2 Smart insulin pen
3.5.3 Insulin Syringes
4 MARKET OUTLOOK
4.1 Evolution of Blood Glucose Monitoring
4.2 Market segmentation
4.3 PEST Analysis
4.4 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 DRO – Global Blood Glucose Monitoring Systems Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing incidence of diabetes across various geographies
5.1.1.2 Increasing number of product launch and approvals
5.1.1.3 Huge surge in the aging population
5.1.2 Opportunities
5.1.2.1 New collaboration and funding to develop new devices
5.1.2.2 Growing patient awareness
5.1.3 Restraints
5.1.3.1 High cost and inadequate reimbursement
5.1.3.2 Product recalls
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 PRODUCTS: MARKET SIZE & ANALYSIS
6.1 Overview
6.2 Self-monitoring Blood Glucose Systems
6.3 Continuous Glucose Monitoring Systems
7 APPLICATION: MARKET SIZE & ANALYSIS
7.1 Overview
7.2 Type 1 Diabetes
7.3 Type 2 Diabetes
7.4 Gestational Diabetes
8 END-USER: MARKET SIZE & ANALYSIS
8.1 Overview
8.2 Hospitals
8.3 Homecare
8.4 Private clinics
8.5 Others
9 REGIONS: MARKET SIZE AND ANALYSIS
9.1 Overview
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World
10 COMPETITIVE LANDSCAPE
10.1 Overview
11 VENDOR PROFILES
11.1 Medtronic plc
11.1.1 Overview
11.1.2 Medtronic plc: Recent Developments
11.1.3 Business Units
11.1.4 Geographic Revenue
11.1.5 Business Focus
11.1.6 SWOT Analysis
11.1.7 Business Strategies
11.2 Abbott Laboratories
11.2.1 Overview
11.2.2 Abbott Laboratories: Recent Developments
11.2.3 Business Units
11.2.4 Geographic Presence
11.2.5 Business Focus
11.2.6 SWOT Analysis
11.2.7 Business Strategies
11.3 Johnson and Johnson
11.3.1 Overview
11.3.2 Business Units
11.3.3 Geographic Revenue
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 F.Hoffmann-La Roche Ltd.
11.4.1 Overview
11.4.2 Business Unit
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategy
12 COMPANIES TO WATCH FOR
12.1 Dexcom
12.1.1 Overview
12.2 PHC Holdings Corporation
12.2.1 Overview
12.3 Ypsomed Holding
12.3.1 Overview
12.4 B. Braun Melsungen AG
12.4.1 Overview
12.5 Trividia Health, Inc.
12.5.1 Overview
12.6 Acon Laboratories
12.6.1 Overview
12.7 Sanofi S.A.
12.7.1 Overview
12.8 Arkray, Inc.
12.8.1 Overview
12.9 Nova Biomedical Corporation
12.9.1 Overview
12.10 Prodigy Diabetes Care, LLC
12.10.1 Overview
12.11 Terumo Medical Corporation
12.11.1 Overview
Annexure
Acronyms
LIST OF TABLES
Table 1 ESTIMATED PERCENTAGE INCREASE IN AGING POPULATION, 2015–2035
Table 2 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS REVENUE BY REGIONS, 2017–2024 ($MILLION)
Table 3 OTHER VENDORS OF BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Table 4 MEDTRONIC PLC: OFFERINGS
Table 5 ABBOTT LABORATORIES: PRODUCT OFFERINGS
Table 6 JOHNSON AND JOHNSON: OFFERINGS
Table 7 JOHNSON AND JOHNSON: RECENT DEVELOPMENTS
Table 8 F. HOFFMANN-LA ROCHE LTD.: OFFERINGS
Table 9 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS
Table 10 DEXCOM, INC.: SNAPSHOT
Table 11 DEXCOM, INC.: RECENT DEVELOPMENTS
Table 12 PHC HOLDINGS CORPORATION: SNAPSHOT
Table 13 PHC HOLDINGS CORPORATION: RECENT DEVELOPMENTS
Table 14 YPSOMED HOLDINGS: SNAPSHOT
Table 15 YPSOMED HOLDING: RECENT DEVELOPMENTS
Table 16 B. BRAUN MELSUNGEN AG: SNAPSHOT
Table 17 B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS
Table 18 TRIVIDIA HEALTH, INC.: SNAPSHOT
Table 19 TRIVIDIA HEALTH, INC.: RECENT DEVELOPMENTS
Table 20 ACON LABORATORIES: SNAPSHOT
Table 21 ACON LABORATORIES: RECENT DEVELOPMENTS
Table 22 SANOFI: SNAPSHOT
Table 23 SANOFI: RECENT DEVELOPMENTS
Table 24 ARKRAY, INC.: SNAPSHOT
Table 25 ARKRAY, INC.: RECENT DEVELOPMENTS
Table 26 NOVA BIOMEDICAL CORPORATION: SNAPSHOT
Table 27 NOVA BIOMEDICAL: RECENT DEVELOPMENTS
Table 28 PRODIGY DIABETES CARE: SNAPSHOT
Table 29 PRODIGY DIABETES CARE: RECENT DEVELOPMENTS
Table 30 TERUMO MEDICAL CORPORATION: SNAPSHOT
Table 31 TERUMO MEDICAL CORPORATION: RECENT DEVELOPMENTS
Table 1 ESTIMATED PERCENTAGE INCREASE IN AGING POPULATION, 2015–2035
Table 2 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS REVENUE BY REGIONS, 2017–2024 ($MILLION)
Table 3 OTHER VENDORS OF BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Table 4 MEDTRONIC PLC: OFFERINGS
Table 5 ABBOTT LABORATORIES: PRODUCT OFFERINGS
Table 6 JOHNSON AND JOHNSON: OFFERINGS
Table 7 JOHNSON AND JOHNSON: RECENT DEVELOPMENTS
Table 8 F. HOFFMANN-LA ROCHE LTD.: OFFERINGS
Table 9 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS
Table 10 DEXCOM, INC.: SNAPSHOT
Table 11 DEXCOM, INC.: RECENT DEVELOPMENTS
Table 12 PHC HOLDINGS CORPORATION: SNAPSHOT
Table 13 PHC HOLDINGS CORPORATION: RECENT DEVELOPMENTS
Table 14 YPSOMED HOLDINGS: SNAPSHOT
Table 15 YPSOMED HOLDING: RECENT DEVELOPMENTS
Table 16 B. BRAUN MELSUNGEN AG: SNAPSHOT
Table 17 B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS
Table 18 TRIVIDIA HEALTH, INC.: SNAPSHOT
Table 19 TRIVIDIA HEALTH, INC.: RECENT DEVELOPMENTS
Table 20 ACON LABORATORIES: SNAPSHOT
Table 21 ACON LABORATORIES: RECENT DEVELOPMENTS
Table 22 SANOFI: SNAPSHOT
Table 23 SANOFI: RECENT DEVELOPMENTS
Table 24 ARKRAY, INC.: SNAPSHOT
Table 25 ARKRAY, INC.: RECENT DEVELOPMENTS
Table 26 NOVA BIOMEDICAL CORPORATION: SNAPSHOT
Table 27 NOVA BIOMEDICAL: RECENT DEVELOPMENTS
Table 28 PRODIGY DIABETES CARE: SNAPSHOT
Table 29 PRODIGY DIABETES CARE: RECENT DEVELOPMENTS
Table 30 TERUMO MEDICAL CORPORATION: SNAPSHOT
Table 31 TERUMO MEDICAL CORPORATION: RECENT DEVELOPMENTS
LIST OF CHARTS
Chart 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION
Chart 2 DIABETES CARE DEVICES MARKET SEGMENTATION
Chart 3 RESEARCH METHODOLOGY OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Chart 4 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE, 2017–2024 ($MILLION)
Chart 5 SEGMENTATION OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Chart 6 PEST ANALYSIS OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Chart 7 PORTER 5 FORCES ON GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Chart 8 DRO – IMPACT ANALYSIS OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Chart 9 KEY STAKEHOLDERS
Chart 10 GLOBAL BLOOD GLUCOSE MONITORING SYSTEM BY PRODUCT SEGMENTATION, 2017 (%)
Chart 11 GLOBAL SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 12 GLOBAL CONTINUOUS BLOOD GLUCOSE SYSTEMS MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 13 GLOBAL BLOOD GLUCOSE MONITORING MARKET BY APPLICATION SEGMENTATION, 2017 (%)
Chart 14 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS BY END-USERS SEGMENTATION, 2017 (%)
Chart 15 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%)
Chart 16 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY GEOGRAPHICAL SEGMENTATION, 2024 (%)
Chart 17 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION)
Chart 18 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION)
Chart 19 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION)
Chart 20 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION)
Chart 21 MEDTRONIC PLC: OVERVIEW SNAPSHOT
Chart 22 MEDTRONIC PLC: BUSINESS UNITS
Chart 23 MEDTRONIC PLC: GEOGRAPHIC REVENUE
Chart 24 MEDTRONIC PLC: SWOT ANALYSIS
Chart 25 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT
Chart 26 ABBOTT LABORATORIES: BUSINESS UNITS REVENUE
Chart 27 ABBOTT LABORATORIES: GEOGRAPHICAL PRESENCE
Chart 28 ABBOTT LABORATORIES: SWOT ANALYSIS
Chart 29 JOHNSON AND JOHNSON: OVERVIEW SNAPSHOT
Chart 30 JOHNSON & JOHNSON: BUSINESS UNITS
Chart 31 JOHNSON & JOHNSON: GEOGRAPHIC REVENUE
Chart 32 JOHNSON & JOHNSON: SWOT ANALYSIS
Chart 33 F. HOFFMANN-LA ROCHE: OVERVIEW SNAPSHOT
Chart 34 F. HOFFMANN.LA ROCHE: BUSINESS UNITS
Chart 35 F. HOFFMANN-LA ROCHE: GEOGRAPHICAL PRESENCE
Chart 36 F. HOFFMANN-LA ROCHE: SWOT ANALYSIS
Chart 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION
Chart 2 DIABETES CARE DEVICES MARKET SEGMENTATION
Chart 3 RESEARCH METHODOLOGY OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Chart 4 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE, 2017–2024 ($MILLION)
Chart 5 SEGMENTATION OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Chart 6 PEST ANALYSIS OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Chart 7 PORTER 5 FORCES ON GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Chart 8 DRO – IMPACT ANALYSIS OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
Chart 9 KEY STAKEHOLDERS
Chart 10 GLOBAL BLOOD GLUCOSE MONITORING SYSTEM BY PRODUCT SEGMENTATION, 2017 (%)
Chart 11 GLOBAL SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 12 GLOBAL CONTINUOUS BLOOD GLUCOSE SYSTEMS MARKET REVENUE FORECAST, 2017–2024 ($MILLION)
Chart 13 GLOBAL BLOOD GLUCOSE MONITORING MARKET BY APPLICATION SEGMENTATION, 2017 (%)
Chart 14 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS BY END-USERS SEGMENTATION, 2017 (%)
Chart 15 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%)
Chart 16 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY GEOGRAPHICAL SEGMENTATION, 2024 (%)
Chart 17 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION)
Chart 18 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION)
Chart 19 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION)
Chart 20 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION)
Chart 21 MEDTRONIC PLC: OVERVIEW SNAPSHOT
Chart 22 MEDTRONIC PLC: BUSINESS UNITS
Chart 23 MEDTRONIC PLC: GEOGRAPHIC REVENUE
Chart 24 MEDTRONIC PLC: SWOT ANALYSIS
Chart 25 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT
Chart 26 ABBOTT LABORATORIES: BUSINESS UNITS REVENUE
Chart 27 ABBOTT LABORATORIES: GEOGRAPHICAL PRESENCE
Chart 28 ABBOTT LABORATORIES: SWOT ANALYSIS
Chart 29 JOHNSON AND JOHNSON: OVERVIEW SNAPSHOT
Chart 30 JOHNSON & JOHNSON: BUSINESS UNITS
Chart 31 JOHNSON & JOHNSON: GEOGRAPHIC REVENUE
Chart 32 JOHNSON & JOHNSON: SWOT ANALYSIS
Chart 33 F. HOFFMANN-LA ROCHE: OVERVIEW SNAPSHOT
Chart 34 F. HOFFMANN.LA ROCHE: BUSINESS UNITS
Chart 35 F. HOFFMANN-LA ROCHE: GEOGRAPHICAL PRESENCE
Chart 36 F. HOFFMANN-LA ROCHE: SWOT ANALYSIS
